- Home
- CDNA vs HSII Comparison
CDNA vs HSII Comparison
Compare CDNA & HSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- HSII
- Stock Information
- Founded
- CDNA 1998
- HSII 1953
- Country
- CDNA United States
- HSII United States
- Employees
- CDNA N/A
- HSII N/A
- Industry
- CDNA Medical Specialities
- HSII Diversified Commercial Services
- Sector
- CDNA Health Care
- HSII Consumer Discretionary
- Exchange
- CDNA Nasdaq
- HSII Nasdaq
- Market Cap
- CDNA 1.1B
- HSII 904.3M
- IPO Year
- CDNA 2014
- HSII 1999
- Fundamental
- Price
- CDNA $18.90
- HSII $41.81
- Analyst Decision
- CDNA Buy
- HSII Buy
- Analyst Count
- CDNA 8
- HSII 2
- Target Price
- CDNA $29.43
- HSII $47.00
- AVG Volume (30 Days)
- CDNA 661.3K
- HSII 160.3K
- Earning Date
- CDNA 04-30-2025
- HSII 05-05-2025
- Dividend Yield
- CDNA N/A
- HSII 1.44%
- EPS Growth
- CDNA N/A
- HSII N/A
- EPS
- CDNA 0.93
- HSII 0.41
- Revenue
- CDNA $333,785,000.00
- HSII $1,098,573,000.00
- Revenue This Year
- CDNA $13.33
- HSII $5.41
- Revenue Next Year
- CDNA $15.07
- HSII $3.97
- P/E Ratio
- CDNA $20.32
- HSII $101.93
- Revenue Growth
- CDNA 19.07
- HSII 6.98
- 52 Week Low
- CDNA $7.42
- HSII $29.03
- 52 Week High
- CDNA $34.84
- HSII $49.02
- Technical
- Relative Strength Index (RSI)
- CDNA 50.38
- HSII 47.80
- Support Level
- CDNA $15.78
- HSII $37.69
- Resistance Level
- CDNA $20.13
- HSII $42.56
- Average True Range (ATR)
- CDNA 1.37
- HSII 1.88
- MACD
- CDNA 0.24
- HSII -0.10
- Stochastic Oscillator
- CDNA 71.72
- HSII 59.54
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.